Leigh N. Pierce
Founder at PacificGMP LLC
Network origin in Leigh N. Pierce first degree
Entity | Entity type | Industry | |
---|---|---|---|
Holding Company | Biotechnology | 5 | |
PacificGMP LLC
PacificGMP LLC Pharmaceuticals: MajorHealth Technology PacificGMP LLC provides an array of development and production services for recombinant proteins, antibodies, cell therapies and vaccines for preclinical and clinical materials. It offers process development, GMP manufacturing, regulatory affairs compliance and single use technology services. The company has offices in Cambridge and San Diego. PacificGMP was founded by Gary Pierce and Leigh N. Pierce in 2005 and is headquartered in San Diego, CA.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Leigh N. Pierce via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BELK INC | Department Stores | Corporate Officer/Principal | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of Manchester | College/University | Graduate Degree | |
Biovation Ltd.
Biovation Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Biovation Ltd. is a British company that develops proprietary pharmaceutical and diagnostic agents. The company is based in Aberdeen, UK. Biovation was acquired by Merck KGaA on October 01, 2000 for $29.28 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Display Systems Biotech As
Display Systems Biotech As Pharmaceuticals: MajorHealth Technology Part of NTG Nordic Transport Group A/S, Display Systems Biotech As is a Danish pharmaceutical company. The company is based in Copenhagen, Denmark. The company was founded by Thomas Warthoe. Display Systems Biotech was acquired by NTG Nordic Transport Group A/S on March 21, 2001 for $3.52 million. | Pharmaceuticals: Major | Director/Board Member | |
Primedica Corp
Primedica Corp Pharmaceuticals: MajorHealth Technology Part of Charles River Laboratories International, Inc., Primedica Corp develops and produces pharmaceutical products for the biopharmaceutical industry. The company is based in Worcester, MA. Primedica was acquired by Charles River Laboratories, Inc. from rEVO Biologics, Inc. on February 27, 2001 for $42.50 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Undergraduate Degree | |
University of San Diego | College/University | Graduate Degree | |
University of Aarhus | College/University | Doctorate Degree | |
University of Birmingham | College/University | Doctorate Degree | |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Medical Specialties | Corporate Officer/Principal | |
California Western School of Law | College/University | Graduate Degree | |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Medical Specialties | Corporate Officer/Principal | |
Real Estate Investment Trusts
Real Estate Investment Trusts Savings BanksFinance Real Estate Investment Trusts is an American company that specializes in savings institutions that are federally chartered. The private company is based in Washington. | Savings Banks | General Counsel | |
Johnson & Johnson Ltd.
Johnson & Johnson Ltd. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Ltd. is a British company that manufactures health care products. The company is based in Maidenhead, UK. Founded in 1987. | Household/Personal Care | Corporate Officer/Principal | |
Cohesive Technologies, Inc.
Cohesive Technologies, Inc. Chemicals: Major DiversifiedProcess Industries Cohesive Technologies, Inc. designs, manufactures, and markets liquid chromatography solutions. It serves to the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company was founded in 1991 and is headquartered in Franklin, MA. | Chemicals: Major Diversified | Corporate Officer/Principal | |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Founder | |
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
OSI Pharmaceuticals (UK) Ltd. | Director/Board Member | ||
FUSION ANTIBODIES PLC | Medical/Nursing Services | Director/Board Member | |
PolyTherics Ltd.
PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Chairman | |
OSI Investment Management GmbH | Director/Board Member | ||
Abzena (Cambridge) Ltd.
Abzena (Cambridge) Ltd. Miscellaneous Commercial ServicesCommercial Services Abzena (Cambridge) Ltd. provides antibody engineering and immunogenicity screening services. The company was founded in 2004 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Crucell UK Ltd.
Crucell UK Ltd. Pharmaceuticals: OtherHealth Technology Crucell UK Ltd. develops, produces, and markets vaccines and antibodies to combat infectious diseases. The private company is based in Bradford, UK. | Pharmaceuticals: Other | Corporate Officer/Principal | |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Aniona ApS
Aniona ApS Medical/Nursing ServicesHealth Services Aniona ApS is a private company based in Ballerup, Denmark. Jørgen Drejer has been the CEOs since incorporation. The Danish company was founded by Thomas Feldthus, Anker Gunvald Lundemose, Claus Tycho Bræstrup, Jørgen Drejer. | Medical/Nursing Services | Founder | |
REVO BIOLOGICS INC | Biotechnology | Corporate Officer/Principal | |
Oxford Genetics Ltd.
Oxford Genetics Ltd. BiotechnologyHealth Technology Oxford Genetics Ltd. produces modular DNA plasmids for biological research. Its products include DNA systems, kits, and cell lines. The company was founded by Ryan Cawood and Leonard Seymour on April 28, 2011 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
SANA AB | Biotechnology | Founder | |
MERCIA ASSET MANAGEMENT PLC | Financial Conglomerates | Director/Board Member | |
Inthera Bioscience AG
Inthera Bioscience AG BiotechnologyHealth Technology Inthera Bioscience AG engages in the research in as well as development, production, and distribution of pharmaceutical, biological, and other products used in the fields of human and veterinary medicine. It also provides related consultancy services. The company was founded by Ulrich Kessler and Paramjit Singh Arora on September 20, 2013 and is headquartered in Zurich, Switzerland. | Biotechnology | Director/Board Member | |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Miscellaneous Commercial Services | Director/Board Member | |
Macrophage Pharma Ltd.
Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Biotechnology | Director/Board Member | |
Antag Therapeutics ApS
Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
BioTesch Advice & Consultancy
BioTesch Advice & Consultancy Investment ManagersFinance BioTesch Advice & Consultancy provides asset management services. The private company is based in Holte City, Denmark. The CEO of the Danish company is Anker Gunvald Lundemose. | Investment Managers | Chief Executive Officer |
Statistics
International
United Kingdom | 19 |
United States | 14 |
Denmark | 14 |
Switzerland | 3 |
Israel | 2 |
Sectoral
Health Technology | 27 |
Commercial Services | 7 |
Consumer Services | 7 |
Finance | 5 |
Retail Trade | 3 |
Operational
Director/Board Member | 24 |
Corporate Officer/Principal | 18 |
Chief Executive Officer | 8 |
Founder | 6 |
Chief Tech/Sci/R&D Officer | 5 |
Most connected contacts
Insiders | |
---|---|
Anker Gunvald Lundemose | 25 |
Matthew Baker | 9 |
Campbell Bunce | 8 |
Gary L. Pierce | 7 |
John F. Manzello | 7 |
Sven Lee | 4 |
John Burt | 1 |
Mike Faughnan | 1 |
- Stock Market
- Insiders
- Leigh N. Pierce
- Company connections